To recover your password please fill in your email address
Please fill in below form to create an account with us
Title: A single arm, open label, signal-seeking, phase II trial of tepotinib in patients with advanced non-small cell lung cancer harbouring MET exon 14 skipping mutations detected by comprehensive genomic profiling.
|
Trial Summary: |
The aim of this ASPiRATION and MoST substudy to evaluate the activity of tepotinib in metastatic non-squamous NSCLC with METex14 mutations detected by CGP |
|
Supported By: |
|
|
Eligibility: |
Adult patients with newly diagnosed metastatic non-squamous NSCLC with METex14 skipping mutation identified using CGP. |
|
Registration ID: |
ACTRN12621000811808 |
|
Participation: |
National |
|
Status: |
Closed |
|
Activation Date: |
23/09/2021 |
|
Study Chairs: |
Associate Professor Chee Khoon Lee and Dr Shalini Subramaniam |
|
Contact: |